270 related articles for article (PubMed ID: 37249550)
1. Cardio-Oncology for the Primary Care Provider.
Jhawar N; Mcpherson A; Chirila R; Ray J
Rom J Intern Med; 2023 Sep; 61(3):127-134. PubMed ID: 37249550
[TBL] [Abstract][Full Text] [Related]
2. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
[TBL] [Abstract][Full Text] [Related]
3. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
Lenneman CG; Sawyer DB
Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
[TBL] [Abstract][Full Text] [Related]
4. The Role of Cardio-Oncology in the Interprofessional Care of Adult Patients Receiving Cancer Therapy.
Pituskin E; Paterson I; Cox-Kennett N; Rothe D; Perri M; Becher H
Semin Oncol Nurs; 2017 Nov; 33(4):384-392. PubMed ID: 28941563
[TBL] [Abstract][Full Text] [Related]
5. Interactions between cardiology and oncology drugs in precision cardio-oncology.
Kamaraju S; Mohan M; Zaharova S; Wallace B; McGraw J; Lokken J; Tierney J; Weil E; Fatunde O; Brown SA
Clin Sci (Lond); 2021 Jun; 135(11):1333-1351. PubMed ID: 34076246
[TBL] [Abstract][Full Text] [Related]
6. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
[TBL] [Abstract][Full Text] [Related]
7. The Year in Cardio-oncology 2022.
Ahmed T; Marmagkiolis K; Ploch M; Irizarry-Caro JA; Amatullah A; Desai S; Aziz MK; Yarrabothula A; Fossas-Espinosa J; Koutroumpakis E; Hassan S; Karimzad K; Kim P; Cilingiroglu M; Iliescu C
Curr Probl Cardiol; 2023 Jan; 48(1):101435. PubMed ID: 36183977
[TBL] [Abstract][Full Text] [Related]
8. What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?
Andres MS; Pan J; Lyon AR
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):483-493. PubMed ID: 33832839
[TBL] [Abstract][Full Text] [Related]
9. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system.
Babiker HM; McBride A; Newton M; Boehmer LM; Drucker AG; Gowan M; Cassagnol M; Camenisch TD; Anwer F; Hollands JM
Crit Rev Oncol Hematol; 2018 Jun; 126():186-200. PubMed ID: 29759560
[TBL] [Abstract][Full Text] [Related]
11. Hypertension management in cardio-oncology.
Essa H; Dobson R; Wright D; Lip GYH
J Hum Hypertens; 2020 Oct; 34(10):673-681. PubMed ID: 32747676
[TBL] [Abstract][Full Text] [Related]
12. Cardio-oncology: rationale, aims and future directions.
Pan J; Garza F; Lyon AR
Curr Opin Support Palliat Care; 2021 Jun; 15(2):134-140. PubMed ID: 33605633
[TBL] [Abstract][Full Text] [Related]
13. Rationale for Cardio-Oncology Units.
Nhola LF; Villarraga HR
Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):583-589. PubMed ID: 28330611
[TBL] [Abstract][Full Text] [Related]
14. Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring.
Mikail N; Chequer R; Imperiale A; Meisel A; Bengs S; Portmann A; Gimelli A; Buechel RR; Gebhard C; Rossi A
Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1129-1145. PubMed ID: 37467476
[TBL] [Abstract][Full Text] [Related]
15. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
[TBL] [Abstract][Full Text] [Related]
16. The Importance of Primary Care in Cardio-Oncology.
Cehic DA; Sverdlov AL; Koczwara B; Emery J; Ngo DTM; Thornton-Benko E
Curr Treat Options Oncol; 2021 Oct; 22(12):107. PubMed ID: 34674055
[TBL] [Abstract][Full Text] [Related]
17. Nuclear cardio-oncology: From its foundation to its future.
Kahanda MG; Hanson CA; Patterson B; Bourque JM
J Nucl Cardiol; 2020 Apr; 27(2):511-518. PubMed ID: 30788760
[TBL] [Abstract][Full Text] [Related]
18. [The Cardio-Oncology Guideline - A Comprehensive Approach to Managing Cardiovascular Risks in Cancer Patients].
Romann SW; Frey N; Lehmann L
Dtsch Med Wochenschr; 2024 Jun; 149(12):719-723. PubMed ID: 38781996
[TBL] [Abstract][Full Text] [Related]
19. Emergence of cardio-oncology.
Nebigil CG; Désaubry L
Ann Pharm Fr; 2018 Nov; 76(6):504-506. PubMed ID: 30075937
[TBL] [Abstract][Full Text] [Related]
20. The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
Parent S; Pituskin E; Paterson DI
Can J Cardiol; 2016 Jul; 32(7):847-51. PubMed ID: 27343743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]